Results
1 -
10 of
11Update in the Therapy of Advanced Neuroendocrine Tumors, Current Treatment Options in Oncology Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea, Cancer Chemotherapy and Pharmacology Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract, Current Treatment Options in Oncology Telotristat Ethyl: First Global Approval, Drugs Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea, Drugs Telotristat for CSD treatment: "minimal" budget impact, PharmacoEconomics & Outcomes News Bessere Lebensqualit??t bei Karzinoid-assoziierter Diarrh??, Im Focus Onkologie Add-on-Therapie verbessert Lebensqualit??t, InFo Onkologie Symptomtherapie beim Karzinoid-Syndrom, Im Focus Onkologie Telotristat etiprate, Reactions Weekly